Document Detail


Pulmonary airflow obstruction following lymphography.
MedLine Citation:
PMID:  7171033     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a series of 27 patients a significant mean decrease of forced expiratory volume in one second (FEV1) was recorded at 1/2, 2, 4 and 24 hours after lymphography with an oily contrast medium, with a maximum mean decrease at 4 hours after injection. The decrease of FEV1 was greater in patients given large amounts of contrast medium at high injection speed. Furthermore, an excessive decrease was observed in patients with metastatic lymph nodes, while a less marked decrease of FEV1 was observed in patients treated with aspirin. No serious clinical side effects were observed. It is recommended that the injection speed and the total amount of contrast medium be limited as far as possible, especially in patients with severe airflow obstruction or with metastases in the lymphatic system. Oral administration of aspirin may limit the decrease in FEV1 following lymphography.
Authors:
P E Andersen; L Heslet; B Elle; L Bastholt
Related Documents :
11458583 - Asthma and copd. inhalation therapy--clarity or confusion?
15132833 - Alterations in circadian rhythms of melatonin and cortisol in patients with bronchial a...
15931033 - Limb length and girth discrepancy of unilateral congenital clubfeet.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta radiologica: diagnosis     Volume:  23     ISSN:  0567-8056     ISO Abbreviation:  Acta Radiol Diagn (Stockh)     Publication Date:  1982  
Date Detail:
Created Date:  1983-06-23     Completed Date:  1983-06-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370367     Medline TA:  Acta Radiol Diagn (Stockh)     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  639-42     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Airway Obstruction / etiology*,  physiopathology
Aspirin / therapeutic use
Female
Forced Expiratory Volume
Humans
Lymphography / adverse effects*,  methods
Male
Middle Aged
Prospective Studies
Chemical
Reg. No./Substance:
50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Computerized quantitation of atherosclerosis in an experimental model. Arteriography and microdensit...
Next Document:  Imaging of a mobile object at computed tomography.